세계의 의료용 종양학 소프트웨어 시장 규모 조사 및 예측 : 도입 유형별, 용도별, 최종사용자별, 지역별 분석(2023-2030년)

Global Medical Oncology Software Market is valued at approximately USD 2.40 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% over during the forecast period 2023-2030. Medical oncology software is a vital oncology informatics system, supporting healthcare providers in the precise administration of systemic cancer treatments such as chemotherapy, targeted therapy, immunotherapy, and hormone therapy. This software streamlines patient data management, treatment planning, medication scheduling, clinical decision support, and monitoring of treatment side effects for oncologists. The overall market growth is fueled by several key factors, including the increasing prevalence of cancer, a rise in research activities utilizing oncology informatics, rising adoption of Electronic Health Records (EHR) for cohesive treatment strategies, development of personalized treatment plans using genomic data the ongoing digitization of healthcare services, and increased investment in enhancing cancer care.

In addition, the surge in cancer cases is set to propel the demand for medical oncology software, crucial for patient record management and treatment planning. There is a significant strain on healthcare systems with the increasing number of new cancer cases globally. Efficient management across diagnosis and treatment becomes imperative, intensifying the need for medical oncology software. For instance, an article published by the American Cancer Society in January 2023 forecasts a rise in new cancer cases to 1,958,310 in 2023, accompanied by an estimated 609,820 cancer-related deaths in the U.S. Additionally, cancer prevalence is higher among geriatric patients due to weakened immunity, further driving the incidence of cancer and consequently fueling market growth throughout the forecast period. Thus, these aforementioned factors are propelling the growth of the Medical Oncology Software Market during the estimated period of 2023-2030. Furthermore, increasing technological advancements and the proliferation of cancer drug development significantly contribute to the present various lucrative opportunities over the forecast years. However, the growing risk of cyber-attacks and data breaching activities and the high cost and complex integration are is challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Medical Oncology Software Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising trend of centralized care, the growing establishment of cancer care centers, and the increase in technological advancements in oncology software. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increase in the incidence of cancer, the expanding aging population, the emergence of key players, growing investment opportunities, and an increasing influx of companies developing oncology software solutions are significantly propelling the market demand across the region. For instance, in August 2022, The National Cancer Grid (NCG) inaugurated the Koita Centre for Digital Oncology (KCDO) aimed at advancing cancer care through digital technologies and tools across India. The KCDO supports NCG hospitals by facilitating the adoption of digital health tools, implementing digital health practices, and spearheading technology initiatives such as healthcare data interoperability and Electronic Medical Record (EMR) adoption.

Major market players included in this report are:

• Epic Systems Corporation (U.S.)
• Altai, Inc. (U.S.)
• Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.)
• Cerner Corporation (Oracle) (U.S.)
• American Medical Software (U.S.)
• Elekta (Sweden)
• EndoSoft LLC (U.S.)
• RaySearch Laboratories (Sweden)
• Mckesson Corporation (U.S.)
• Koninklijke Philips N.V. (Netherlands)

Recent Developments in the Market:

• In April 2023, Epic Systems Corporation announced an expansion of its collaboration with Microsoft, focusing on integrating generative artificial Artificial intelligence Intelligence (AI) technology into electronic health records. This partnership aims to enhance providers' productivity, alleviate administrative burdens, and elevate patient care by granting clinicians more time to dedicate to their patients.
• In February 2023, Varian Medical Systems, Inc., operating under Siemens Healthineers, unveiled its collaboration with Nova Scotia Health to expedite the digital transformation of the health system's comprehensive oncology service line. Through this collaboration, Varian Medical Systems, Inc. endeavours to offer a range of multidisciplinary oncology solutions aimed at fostering connectivity among cancer patients and optimizing patient care across their entire cancer care continuum.

Global Medical Oncology Software Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Deployment Type, Application, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Deployment Type:

• Clouds
• On-premise
• Hybrid

By Application:

• Treatment Planning
• Patient Record Management
• Clinical Decision Support
• Others

By End User:

• Hospitals & Specialty Clinics
• Diagnostic Centers
• Research Institutes
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Medical Oncology Software Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Medical Oncology Software Market, by Deployment Type, 2020-2030 (USD Billion)
  • 1.2.3.Medical Oncology Software Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Medical Oncology Software Market, by End User, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Medical Oncology Software Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Medical Oncology Software Market Dynamics

• 3.1.Medical Oncology Software Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing adoption of Electronic Health Records (EHR) for cohesive treatment strategies
    • 3.1.1.2.Surge in cancer cases
  • 3.1.2.Market Challenges
    • 3.1.2.1.Growing risk of cyber-attack and data breaching activities
    • 3.1.2.2.High cost and complex integration
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Increasing technological advancements
    • 3.1.3.2.Rapid proliferation of cancer drug development

Chapter 4.Global Medical Oncology Software Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Medical Oncology Software Market, by Deployment Type

• 5.1.Market Snapshot
• 5.2.Global Medical Oncology Software Market by Deployment Type, Performance - Potential Analysis
• 5.3.Global Medical Oncology Software Market Estimates & Forecasts by Deployment Type 2020-2030 (USD Billion)
• 5.4.Medical Oncology Software Market, Sub Segment Analysis
  • 5.4.1.Clouds
  • 5.4.2.On-premise
  • 5.4.3.Hybrid

Chapter 6.Global Medical Oncology Software Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Medical Oncology Software Market by Application, Performance - Potential Analysis
• 6.3.Global Medical Oncology Software Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Medical Oncology Software Market, Sub Segment Analysis
  • 6.4.1.Treatment Planning
  • 6.4.2.Patient Record Management
  • 6.4.3.Clinical Decision Support
  • 6.4.4.Others

Chapter 7.Global Medical Oncology Software Market, by End User

• 7.1.Market Snapshot
• 7.2.Global Medical Oncology Software Market by End User, Performance - Potential Analysis
• 7.3.Global Medical Oncology Software Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 7.4.Medical Oncology Software Market, Sub Segment Analysis
  • 7.4.1.Hospitals & Specialty Clinics
  • 7.4.2.Diagnostic Centers
  • 7.4.3.Research Institutes
  • 7.4.4.Others

Chapter 8.Global Medical Oncology Software Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Medical Oncology Software Market, Regional Market Snapshot
• 8.4.North America Medical Oncology Software Market
  • 8.4.1.U.S. Medical Oncology Software Market
    • 8.4.1.1.Deployment Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Medical Oncology Software Market
• 8.5.Europe Medical Oncology Software Market Snapshot
  • 8.5.1.U.K. Medical Oncology Software Market
  • 8.5.2.Germany Medical Oncology Software Market
  • 8.5.3.France Medical Oncology Software Market
  • 8.5.4.Spain Medical Oncology Software Market
  • 8.5.5.Italy Medical Oncology Software Market
  • 8.5.6.Rest of Europe Medical Oncology Software Market
• 8.6.Asia-Pacific Medical Oncology Software Market Snapshot
  • 8.6.1.China Medical Oncology Software Market
  • 8.6.2.India Medical Oncology Software Market
  • 8.6.3.Japan Medical Oncology Software Market
  • 8.6.4.Australia Medical Oncology Software Market
  • 8.6.5.South Korea Medical Oncology Software Market
  • 8.6.6.Rest of Asia Pacific Medical Oncology Software Market
• 8.7.Latin America Medical Oncology Software Market Snapshot
  • 8.7.1.Brazil Medical Oncology Software Market
  • 8.7.2.Mexico Medical Oncology Software Market
• 8.8.Middle East & Africa Medical Oncology Software Market
  • 8.8.1.Saudi Arabia Medical Oncology Software Market
  • 8.8.2.South Africa Medical Oncology Software Market
  • 8.8.3.Rest of Middle East & Africa Medical Oncology Software Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.Epic Systems Corporation (U.S.)
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Altai, Inc. (U.S.)
  • 9.3.3.Varian Medical Systems, Inc. (Siemens Healthineers AG) (U.S.)
  • 9.3.4.Cerner Corporation (Oracle) (U.S.)
  • 9.3.5.American Medical Software (U.S.)
  • 9.3.6.Elekta (Sweden)
  • 9.3.7.EndoSoft LLC (U.S.)
  • 9.3.8.RaySearch Laboratories (Sweden)
  • 9.3.9.Mckesson Corporation (U.S.)
  • 9.3.10.Koninklijke Philips N.V. (Netherlands)

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption